Company Profile
Guangzhou Pi & Pi Biotech Inc. was set up in Guangzhou Privately-Run Science and Technology Park In 2009.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Amoxicillin |
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-,(2S,5R,6R)-;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-,[2S-[2α,5α,6β(S*)]]-;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[2-amino-2-(p-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-,D-;4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[(2R)-amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-,(2S,5R,6R)-;(2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;6-[D(-)-α-Amino-p-hydroxyphenylacetamido]penicillanic acid;Amoxicillin;Amoxycillin;BRL 2333;6-[D-(-)-2-Amino-2-(p-hydroxyphenyl)acetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;D-(-)-α-Amino-p-hydroxybenzyl penicillin;D-(α-Amino-p-hydroxybenzyl)penicillin;p-Hydroxyampicillin;Histocillin;Amoxil;6-[D-(-)-p-Hydroxy-α-aminobenzyl]penicillin;D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid;Clamoxyl;BLP 1410;6-[D-α-Amino-α-(4-hydroxyphenyl)acetamido]penicillanic acid;Imacillin;D-Amoxicillin;Amopen;Sawacillin;Amoclen;Cemoxin;Amoxipen;Anemolin;Bristamox;Delacillin;Aspenil;Ibiamox;Piramox;Sumox;Amopenixin;Ampy-Penyl;Amoxi;Efpenix;Amolin;Amoxi-Mast;Metifarma capsules;Metafarma capsules;Hiconcil;Amoxivet;Vetramox;33911-69-2;71447-36-4;81030-75-3;1236363-38-4 |
26787-78-0 | - / 95% | Inquiry |
Bardoxolone |
2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid;Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-;Bardoxolone;CDDO;RTA 401;2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid;Bardoxolone (CDDO);(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-1,3,4,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-hexadecahydropicene-4a(2H)-carboxylic acid |
218600-44-3 | - / 90% | Inquiry |
Bardoxolone methyl |
Oleana-1,9(11)-dien-28-oic acid,2-cyano-3,12-dioxo-,methyl ester;CDDO-Me;Methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate;CDDO Methyl ester;RTA 402;NSC 713200;Bardoxolone methyl;2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl ester;2-Cyano-3,12-dioxoolen-1,9-dien-28-oic acid methyl ester;DCL 000217 |
218600-53-4 | - / 98% | Inquiry |
Cefaclor Impurity D (EP) |
CEFACLOR, DELTA-3-ISOMER (30 MG);δ-3 Cefaclor;(2R,6R,7R)- and (2S,6R,7R)-7-{[(2R)-2-Amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid |
152575-13-8 | - / 90% | Inquiry |
Cefamandole Nafate |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,sodium salt (1:1),(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt,[6R-[6α,7β(R*)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodium salt,(6R,7R)-;Cefamandole nafate;Sodium 7-(D-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate;O-Formylcefamandole sodium;Cefamandole formate sodium;Cephamandole nafate;Mandol;Kefadol;Sodium O-formylcefamandole;Neocefal;Mandokef;Mandolsan;Cemandil;Pavecef;Kefandol;Bergacef;Cefiran;Cefam;Fado;Lampomandol;Cedol;Cemado;NSC 299588 |
42540-40-9 | - / 90% | Inquiry |
Cefazolin Impurity A (EP) |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-,(6R-trans)-;(6R,7R)-7-Amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;7-Amino-3-[(5-methyl-1,3,4-thiadiazol-2-ylthio)methyl]-3-cephem-4-carboxylic acid;7-Amino-3-[(2-methyl-1,3,4-thiadiazol-5-ylthio)methyl]-3-cephem-4-carboxylic acid;7-Amino-3-(5-methyl-1,3,4-thiadiazol-2-ylthiomethyl)-δ-3-cephem-4-carboxylic acid;(6R-trans)-7-Amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;7-ZACA;24209-41-4;40352-24-7;685897-87-4;847046-98-4;847047-10-3;847222-53-1;849720-42-9;1214004-46-2;1218546-37-2;1252816-01-5;1260684-34-1;1266375-21-6;1276357-97-1;1282672-87-0;1291016-01-7;1312356-98-1;1323050-17-4;1351398-01-0;1352998-98-1;1354064-95-1;1371070-99-3;1381759-40-5;1458498-86-6;1524717-45-0;1638708-03-8;1792191-52-6 |
30246-33-4 | - / 90% | Inquiry |
Cefdinir |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2-amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-,[6R-[6α,7β(Z)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-,(6R,7R)-;(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(hydroxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;FK 482;BMY 28488;Cefdinir;CI 983;Cefzon;CFDN;Adcef;Omnicef;Cefnil;Cefdiel;Kefnir;Zinir |
91832-40-5 | - / 90% | Inquiry |
Cefdinir Impurity M(CP) |
Cefdinir Lactone;(αZ)-2-AMino-α-(hydroxyiMino)-N-[(5aR,6R)-1,4,5a,6-tetrahydro-3-Methyl-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]-4-thiazoleacetaMide;Cefdinir Lactone Discontinued;(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)-N-{(3RS,5aR,6R)-3-methyl-1,7-dioxo-1,3,4,5a,6,7- hexahydroazeto [2,1-b]furo[3,4-d][1,3]thiazin-6-yl}acetamide |
946573-41-7 | - / 95% | Inquiry |
Cefdinir Impurity O(CP) |
Cefdinir Related Compound B (10 mg) ((6R,7R)-7-[2-(2-amino-4-thiazolyl)acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid);(6R,7R)-7-[2-(2-aMino-4-thiazolyl)acetaMido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid;Cefdinir Related CoMpound B;(6R,7R)-7-(2-(2-aMinothiazol-4-yl)acetaMido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(6R-trans)-7-[[(2-AMino-4-thiazolyl)acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid |
79350-10-0 | - / 95% | Inquiry |
Cefixime |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2-amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-,[6R-[6α,7β(Z)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-,(6R,7R)-;(6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;FK 027;FR 17027;Cefixime;CL 284635;Oroken;Cephoral;Suprax;Unixime;Cefixoral;Cefspan;Cefixim;(-)-Cefixim;Loprax;Cefiximine;Suprax (antibiotic);Fixitil;Ximacef;Cefexy;Hifen;Taxim-O;Ceftas;Cefoceb;Zifi;Fixx;214265-67-5 |
79350-37-1 | - / 90% | Inquiry |
Cefixime Imp A(EP) |
α-[[(Z)-2-(2-aMino-4-thiazolyl)-2-[(carboxyMethoxy)iMino]acetyl]aMino]-2-[(2R)-5-Methyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]acetic Acid;CefixiMe EP IMpurity A |
1335475-08-5 | - / 95% | Inquiry |
Cefixime Imp B(EP) |
2-[[(Z)-[1-(2-aMino-4-thiazolyl)-2-[[[(2R,5RS)-5-Methyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]Methyl]aMino]-2-oxoethylidene]aMino]oxy]acetic Acid;CefixiMe EP IMpurity B;Cefixime Impurity B (Mixture of Diastereomers) (EP) |
1335475-19-8 | - / 95% | Inquiry |
Cefixime Imp C(EP) |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-, [6R-[6α,7α(Z)]]-;(6R,7S)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(carboxyMethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;[6R-[6α,7α(Z)]]-7-[[(2-AMino-4-thiazolyl)[(ca;7-epi-CefixiMe (CefixiMe EP IMpurity C);CefixiMe 7-EpiMer;CefixiMe EP IMpurity C (CefixiMe 7-epiMer);Cefixime Impurity C (EP) (Cefixime 7-epimer );(6R,7S)-7-((Z)-2-(2-aminothiazol-4-yl)-2-((carboxymethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
108691-83-4 | - / 95% | Inquiry |
Cefixime Imp E(EP) |
(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(carboxyMethoxy)iMino]acetyl]aMino]-3-Methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;[6R-[6α,7β(Z)]]-7-[[(2-AMino-4-thiazolyl)[(carbox;3-Desethenyl-3-Methyl CefixiMe (CefixiMe EP IMpurity E);(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cefixime EP impurity E |
72701-01-0 | - / 95% | Inquiry |
Cefixime Imp F(EP) |
(6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-[(2-ethoxy-2-oxoethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;[6R-[6α,7β(Z)]]-7-[[(2-AMino-4-thiazolyl)[(2-ethoxy-;CefixiMe Ethyl Ester (CefixiMe EP IMpurity F);CefixiMe Ethyl Ester SodiuM Salt (CefixiMe EP IMpurity F) |
79368-95-9 | - / 95% | Inquiry |
Cefoxitin Impurity C (EP) |
Cephalonium lactone;Cefalonium Impurity C;N-((6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-2-(thiophen-2-yl)acetamide;Cefalotin Impurity D;Cefoxitin EP Impurity C;Deacetylcephalothin Lactone |
10590-10-0 | - / 90% | Inquiry |
Cefradine |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[(amino-1,4-cyclohexadien-1-ylacetyl)amino]-3-methyl-8-oxo-,[6R-[6α,7β(R*)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-amino-1,4-cyclohexadien-1-ylacetyl]amino]-3-methyl-8-oxo-,(6R,7R)-;(6R,7R)-7-[[(2R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Cephradin;Cefradine;Cephradine;7-[D-α-Amino-(1,4-cyclohexadienyl)acetamide]-3-desacetoxycephalosphoranic acid;Sefril;Velosef;SQ 11436;Eskacef;Cefro;Cefrag;Cesporan;Dimacef;Ecosporina;Anspor;Celex;Cefradex;Lisacef;Lenzacef;Velocef;Samedrin;Megacef;Easkacef;Cefradin |
38821-53-3 | - / 90% | Inquiry |
Ceftazidime Impurity C |
Pyridinium,1-[[(6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-,inner salt;Pyridinium,1-[(7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl]-,hydroxide,inner salt;Pyridinium,1-[(7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl]-,inner salt,(6R-trans)-;1-[(7-Amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl]pyridinium hydroxide,inner salt;[7-Amino-3-(1-pyridylmethyl)-3-cephem-4-carboxylic acid;N-(7-Aminocephem-3-em-3-ylmethyl)pyridinium-4-carboxylate;N-(7-Aminoceph-3-em-3-ylmethyl)pyridinium-4-carboxylate |
3432-88-0 | - / 92% | Inquiry |
Ceftriaxone Impurity A (EP) 【(E)-Ceftriaxone】 |
(E)-Ceftriaxone;(6R,7R)-7-[[(2E)-2-(2-AMino-4-thiazolyl)-2-(MethoxyiMino)acetyl]aMino]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-Methyl-5,6-dioxo-1,2,4-triazin-3-yl)thio]Methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;Ro 15-2254;(6R,7R)-7-[[(2E)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2-methyl-5, 6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
92143-31-2 | - / 90% | Inquiry |
Ceftriaxone Impurity B (EP) (3-Desacetyl Cefotaxime Lactone ) |
3-Desacetyl CefotaxiMe Lactone;[5aR-[5aα,6β(Z)]]-2-AMino-α-(MethoxyiMino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-4-thiazoleacetaMide;3-Desacetyl CefotaxiMe Lactone (IMpurity E);Ceftriaxone IMpurity B;CefotaxiMe Related CoMpound E;Cefotaxime EP Impurity B;Ceftriaxone Sodium EP Impurity B(Cefotaxime EP Impurity E);Deacetylcefotaxime lactone ,Cefotaxime Impurity E (EP) |
66340-33-8 | - / 90% | Inquiry |